Free Trial

Incannex Healthcare (IXHL) Competitors

Incannex Healthcare logo
$1.05 -0.58 (-35.58%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.10 +0.05 (+5.24%)
As of 07/25/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IXHL vs. DARE, NRSN, MIRA, NNVC, FBLG, TPST, ALXO, QTTB, CVKD, and TENX

Should you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include Dare Bioscience (DARE), NeuroSense Therapeutics (NRSN), MIRA Pharmaceuticals (MIRA), NanoViricides (NNVC), FibroBiologics (FBLG), Tempest Therapeutics (TPST), ALX Oncology (ALXO), Q32 Bio (QTTB), Cadrenal Therapeutics (CVKD), and Tenax Therapeutics (TENX). These companies are all part of the "pharmaceutical products" industry.

Incannex Healthcare vs. Its Competitors

Dare Bioscience (NASDAQ:DARE) and Incannex Healthcare (NASDAQ:IXHL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

6.7% of Dare Bioscience shares are owned by institutional investors. Comparatively, 0.4% of Incannex Healthcare shares are owned by institutional investors. 4.0% of Dare Bioscience shares are owned by company insiders. Comparatively, 15.5% of Incannex Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Dare Bioscience presently has a consensus price target of $12.00, suggesting a potential upside of 366.93%. Given Dare Bioscience's stronger consensus rating and higher possible upside, equities analysts plainly believe Dare Bioscience is more favorable than Incannex Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dare Bioscience
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Incannex Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Dare Bioscience is trading at a lower price-to-earnings ratio than Incannex Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dare Bioscience$10K2,274.45-$4.05M-$0.17-15.12
Incannex Healthcare$10K3,090.15-$18.46M-$1.21-0.87

Dare Bioscience has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Incannex Healthcare has a beta of 7.47, suggesting that its share price is 647% more volatile than the S&P 500.

Dare Bioscience's return on equity of 0.00% beat Incannex Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Dare BioscienceN/A N/A -8.14%
Incannex Healthcare N/A -342.92%-148.64%

In the previous week, Incannex Healthcare had 4 more articles in the media than Dare Bioscience. MarketBeat recorded 7 mentions for Incannex Healthcare and 3 mentions for Dare Bioscience. Dare Bioscience's average media sentiment score of 0.63 beat Incannex Healthcare's score of 0.37 indicating that Dare Bioscience is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Dare Bioscience
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Incannex Healthcare
0 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Dare Bioscience beats Incannex Healthcare on 9 of the 14 factors compared between the two stocks.

Get Incannex Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IXHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IXHL vs. The Competition

MetricIncannex HealthcareMED IndustryMedical SectorNASDAQ Exchange
Market Cap$47.98M$2.49B$5.69B$9.50B
Dividend YieldN/A1.65%4.58%4.01%
P/E Ratio-0.879.0528.1020.05
Price / Sales3,090.15612.51432.4490.07
Price / CashN/A165.2136.2258.56
Price / Book5.835.168.665.87
Net Income-$18.46M$30.99M$3.25B$258.55M
7 Day Performance72.13%7.74%4.23%3.74%
1 Month Performance402.15%16.27%10.52%11.75%
1 Year Performance-51.54%-1.88%34.41%18.03%

Incannex Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IXHL
Incannex Healthcare
0.7438 of 5 stars
$1.05
-35.6%
N/A-51.4%$47.98M$10K-0.873News Coverage
Gap Down
DARE
Dare Bioscience
1.7944 of 5 stars
$3.09
+22.6%
$12.00
+288.3%
-28.6%$27.35M$10K-18.1830High Trading Volume
NRSN
NeuroSense Therapeutics
2.711 of 5 stars
$2.00
-3.4%
$14.00
+600.0%
+150.6%$27.33MN/A-3.7010
MIRA
MIRA Pharmaceuticals
2.5957 of 5 stars
$1.54
+20.3%
$14.00
+809.1%
-43.1%$26.06MN/A-3.022High Trading Volume
NNVC
NanoViricides
0.3562 of 5 stars
$1.60
+14.7%
N/A-24.0%$25.72MN/A-2.2220High Trading Volume
FBLG
FibroBiologics
3.8169 of 5 stars
$0.64
+1.7%
$13.00
+1,931.3%
-85.8%$25.40MN/A-3.0510Positive News
Gap Up
TPST
Tempest Therapeutics
2.3334 of 5 stars
$6.90
-0.7%
$30.00
+334.8%
-65.3%$25.39MN/A-0.3820Positive News
ALXO
ALX Oncology
3.8518 of 5 stars
$0.47
-2.8%
$3.30
+603.9%
-91.4%$25.03MN/A-0.1940Positive News
QTTB
Q32 Bio
2.4823 of 5 stars
$2.03
-23.7%
$12.17
+499.3%
-94.2%$24.77M$1.16M-0.4139News Coverage
High Trading Volume
CVKD
Cadrenal Therapeutics
3.1047 of 5 stars
$12.50
-3.3%
$32.00
+156.0%
N/A$24.59MN/A-1.354Positive News
TENX
Tenax Therapeutics
1.8082 of 5 stars
$5.90
+1.7%
$17.50
+196.6%
+82.2%$24.47MN/A-2.389Positive News

Related Companies and Tools


This page (NASDAQ:IXHL) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners